ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752270; 2) Community: the network communities that were significantly associated with the response to NSC 752270; 3) Molecule: the relationships between components within communities and NSC 752270; 4) MDR: the compounds that were significantly associated with the NSC 752270.

NSC Compound Enrichment Correlation
NSC 724910 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10,10'-[(2-hydroxy-1,3-propanediyl)bis(oxy)] bis[decahydro- 3,6,9-trimethyl-, hemisuccinate 0.0114553853234976 0.47173601
NSC 725202 Null 0.0114553853234976 0.36817671
NSC 727298 6-[(3-Thiomorpholyl)-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9 -methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0114553853234976 -0.11551447
NSC 746248 Null 0.0114553853234976 -0.076550899
NSC 95382 Camptothecin Derivative 0.0114553853234977 -0.12261732
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.0126882509540132 0.11311401
NSC 49520 o-Tolualdehyde, 4-(bis(2-chloroethyl)amino)- 0.0126882509540132 -0.12944929
NSC 606869 Clofarabine 0.0126882509540132 0.081565649
NSC 650958 Null 0.0126882509540132 0.17611108
NSC 684910 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer B)-, stereoisomer of NSC-684909 0.0126882509540132 0.22583406
Total:47  Current:13    [First] [Prev] [Next] [Last]